Researchers flag safety gaps in widely used birth control pill

A new critical assessment of a prolonged-release contraceptive containing ethinyl estradiol and dienogest has identified previously overlooked safety concerns, prompting regulatory and clinical scrutiny. The findings could reshape how manufacturers and healthcare systems evaluate existing hormone formulations and inform labeling decisions.

Originaltitel: Critical assessment of a prolonged-release EE/DNG contraceptive safety analysis